W.L.Gore receives new FDA Approval and CE Mark on two innovative technologies

Its been a banner week for the medical division of W.L. Gore & Associates.  The Flagstaff-based medical device company announced FDA approval of its GORE VIABAHN Endoprosthesis with Heparin Bioactive Surface on November 6, 2013 followed by the announcement of receiving a CE mark for its the GORE EXCLUDER  Iliac Branch Endoprosthesis on November 7, 2013. Continue reading

W.L. Gore & Associates, Inc. Named 2013 Arizona Bioscience Company of the Year

W.L. Gore & Associates will be honored at the 2013 AZBio Awards as the  Arizona Bioscience Company of the Year by the Arizona Bioindustry Association in recognition of the development of the extensive Gore Medical family of products including vascular grafts, endovascular and interventional devices, and surgical meshes by its world class team of innovators in Flagstaff and Phoenix. Continue reading